The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligands-Reference-Cited by-同舟云学术

The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligands

Published:2024-08-14 Issue: Volume: Page:
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Tissino Erika^ORCID,Gaglio Annalisa,Nicolò Antonella,Pozzo Federico^ORCID,Bittolo Tamara,Rossi Francesca Maria^ORCID,Bomben Riccardo^ORCID,Nanni Paola,Cattarossi Ilaria,Zaina Eva,Zimbo Anna Maria,Ianna Giulia,Capasso Guido,Forestieri Gabriela,Moia Riccardo^ORCID,Datta Moumita,Härzschel Andrea,Olivieri Jacopo,D’Arena Giovanni^ORCID,Laurenti Luca,Zaja Francesco,Chiarenza Annalisa,Palumbo Giuseppe A.^ORCID,Martino Enrica Antonia,Gentile Massimo^ORCID,Rossi Davide,Gaidano Gianluca,Del Poeta Giovanni,Laureana Roberta,Del Principe Maria Ilaria,Maity Palash C.,Jumaa Hassan^ORCID,Hartmann Tanja Nicole^ORCID,Zucchetto Antonella,Gattei Valter^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41375-024-02376-7.pdf

Reference59 articles.

1. Bulian P, Shanafelt TD, Fegan C, Zucchetto A, Cro L, Nückel H, et al. CD49d is the strongest flow cytometry-based predictor of overall survival in chronic lymphocytic leukemia. J Clin Oncol. 2014;32:897–904.

2. Gattei V, Bulian P, Del Principe MI, Zucchetto A, Maurillo L, Buccisano F, et al. Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia. Blood. 2008;111:865–73.

3. Shanafelt TD, Geyer SM, Bone ND, Tschumper RC, Witzig TE, Nowakowski GS, et al. CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential. Br J Haematol. 2008;140:537–46.

4. Ruoslahti E. Integrins. J Clin Investig. 1991;87:1–5.

5. Tissino E, Pivetta E, Capuano A, Capasso G, Bomben R, Caldana C, et al. Elastin MIcrofibriL INterfacer1 (EMILIN-1) is an alternative prosurvival VLA-4 ligand in chronic lymphocytic leukemia. Hematol Oncol. 2022;40:181–90.